Cardiotens low price

$20.00 CPAactive✓ verified live 6h ago

dr.cash · Hypertension · GT · live 16 days · compare this product across geos & networks →

Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.

Run this offer — join dr.cash

Cardiotens low price

Should you run this?

Flow
CPA
Avg. approval
10.91%

Payout history

$15.00$20.00$25.0012 Jul 202628 Jul 2026$20.00
Payout unchanged since we first saw this offer on 12 Jul 2026 — tracked on every refresh.

Traffic & compliance

Cardiotens - capsules for hypertension

Cardiotens - a modern drug based on natural plant components to combat hypertension and high blood pressure. Cardiotens capsules have a complex effect on the cardiovascular system and the patient's body as a whole. It is characterized by high efficiency, affordable price and the absence of any adverse reactions.

CC working hours :Mon-Sun: 08:00-22:00 (Local time)


Target audience:  Male and female age 35+
 

Change log (17 events)

ObservedTypeFieldOldNew
7/12/2026offer_new
7/13/2026approval_rate_changedapproval_rate8.818.84
7/14/2026approval_rate_changedapproval_rate8.849.49
7/15/2026approval_rate_changedapproval_rate9.499.92
7/16/2026approval_rate_changedapproval_rate9.9210
7/17/2026approval_rate_changedapproval_rate109.57
7/18/2026approval_rate_changedapproval_rate9.5710.28
7/19/2026approval_rate_changedapproval_rate10.2810.83
7/20/2026approval_rate_changedapproval_rate10.838.79
7/21/2026approval_rate_changedapproval_rate8.798.89
7/22/2026approval_rate_changedapproval_rate8.899.88
7/23/2026approval_rate_changedapproval_rate9.888.97
7/24/2026approval_rate_changedapproval_rate8.979.72
7/25/2026approval_rate_changedapproval_rate9.728.96
7/26/2026approval_rate_changedapproval_rate8.969.38
7/27/2026approval_rate_changedapproval_rate9.388.77
7/28/2026approval_rate_changedapproval_rate8.7710.91

Reviews (0)

No reviews yet — be the first to share your experience.

Log in or create a free account to review this offer.

Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.